Karyopharm Therapeutics Inc. buy Royal Bank of Canada
Start price
03.08.23
/
50%
€1.67
Target price
03.08.24
€3.65
Performance (%)
-37.00%
Price
03.05.24
€1.05
Summary
This prediction is currently active. Massive losses of -37.00% have been the result for the BUY prediction by Royal_Bank_of_Canada. This prediction currently runs until 03.08.24. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Karyopharm Therapeutics Inc. | 5.303% | 5.303% |
| iShares Core DAX® | -0.922% | -1.993% |
| iShares Nasdaq 100 | 0.371% | -0.868% |
| iShares Nikkei 225® | 2.224% | -5.187% |
| iShares S&P 500 | -0.026% | -0.918% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Karyopharm Therapeutics Inc. diskutieren
Karyopharm Therapeutics Inc. (NASDAQ: KPTI) had its price target lowered by analysts at Royal Bank of Canada from $5.00 to $4.00. They now have an "outperform" rating on the stock.
Ratings data for KPTI provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.84
03.11.23
03.11.23
€2.80
03.11.24
03.11.24
25.39%
03.05.24
03.05.24
